Dental medtech with the first peptide formulation that treats early caries without a drill.
| Date | Round | Amount |
|---|---|---|
| Apr 2026 | Growth Switzerland's vVARDIS became a unicorn with a strategic minority investment (undisclosed amount) from funds managed by Apollo. | — |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.